# The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

Study · id `cardio:ct-nct07143019` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07143019](<https://clinicaltrials.gov/study/NCT07143019>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07143019

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 214 participants.

## Technical summary

Registry record NCT07143019. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 214 participants (planned count; ClinicalTrials.gov record NCT07143019, source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)
- Started: 2026-03-16 (actual) (ClinicalTrials.gov record NCT07143019, source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT07143019, source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)
- Completion: 2032-07 (anticipated) (ClinicalTrials.gov record NCT07143019, source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07143019, source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07143019-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
- Acronym: PIANO
- Condition: Hemorrhagic Stroke
- Condition: Aneurysm, Intracranial
- Condition: Saccular Aneurysm
- Condition: Fusiform Aneurysm
- Condition: Brain Aneurysm
- Intervention (Device): Flow diversion
- Lead sponsor: phenox Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Phenox GmbH
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Phenox GmbH (`cardio:org-phenox-gmbh`)

## Provenance

Content hash: 244ebe39a970791be31dab305230e388ace22859348b12f7ee2007686d5e1b73
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
